What does INFILISA do?

INFILISA is a healthcare practice in Doische. Private Limited, started on 2 July 2019, 1 establishment.

What is the address of INFILISA?

The registered office of INFILISA is located at Route d'Agimont (VOD) 84 box A, 5680 Doische.

Is INFILISA still active?

Yes. According to the CBE (30 October 2026) INFILISA is active, legal situation “Normale toestand”, started on 2 July 2019.

Is INFILISA registered on Peppol?

Yes, INFILISA is registered on the Peppol network with ID 0208:0729702789.

What is the enterprise number of INFILISA?

The enterprise number of INFILISA is BE0729702789.

When was INFILISA founded?

INFILISA was founded on 2 July 2019.

Who are the directors of INFILISA?

According to the 2025 annual accounts, the directors of INFILISA are: Nicolas Vekeman.

Is INFILISA a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 2 July 2019; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did INFILISA make in 2025?

INFILISA posted a profit after taxes of € 11,711 in financial year 2025.

What is the revenue of INFILISA?

As a small company, INFILISA is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 43,898.

INFILISA (Private Limited) - Doische - BE0729702789

Dossier INFILISA, printed on 30 October 2026 from databakkes.be/en/0729702789/infilisa. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 44 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

INFILISA from Doische, company number BE0729702789, closed financial year 2025 with a result of € 11,711 after tax. For that financial year INFILISA recorded a gross margin of € 43,898 and equity of € 37,000. Compared with financial year 2024, the result moved from € 17,019 to € 11,711. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 10, 2026.

What it is worth Healthy

€ 37,000

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 11,711

▼ 31% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 6,750

▲ 133% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 11,711 paid out

100 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 194

▼ 85% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 1 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 22,136

▼ 54% vs 2024

€ 21,227 is repaid this year. At this pace the long-term loan is gone in ≈ 1 years.

Owed to suppliers

€ 12,822

▲ 203% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 14,952

▼ 29% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 21,835 Gross margin 2022: € 21,835 First fiscal year in the series	€ 27,163 Gross margin 2023: € 27,163 ▲ 24% vs 2022 (€ 21,835) Favourable step	€ 44,087 Gross margin 2024: € 44,087 ▲ 62% vs 2023 (€ 27,163) Favourable step	€ 43,898 Gross margin 2025: € 43,898 Unchanged (€ 44,087) Unfavourable step
Profit after taxes	€ 1,341 Profit after taxes 2022: € 1,341 First fiscal year in the series	€ 4,451 Profit after taxes 2023: € 4,451 ▲ 232% vs 2022 (€ 1,341) Favourable step	€ 17,019 Profit after taxes 2024: € 17,019 ▲ 282% vs 2023 (€ 4,451) Favourable step	€ 11,711 Profit after taxes 2025: € 11,711 ▼ 31% vs 2024 (€ 17,019) Unfavourable step	▼ 31%
Equity	€ 83,002 Equity 2022: € 83,002 First fiscal year in the series	€ 87,453 Equity 2023: € 87,453 ▲ 5% vs 2022 (€ 83,002) Favourable step	€ 37,000 Equity 2024: € 37,000 ▼ 58% vs 2023 (€ 87,453) Unfavourable step	€ 37,000 Equity 2025: € 37,000 Unchanged (€ 37,000) Unchanged
Total debts	€ 103,334 Total debts 2022: € 103,334 First fiscal year in the series	€ 84,583 Total debts 2023: € 84,583 ▼ 18% vs 2022 (€ 103,334) Favourable step	€ 74,063 Total debts 2024: € 74,063 ▼ 12% vs 2023 (€ 84,583) Favourable step	€ 66,467 Total debts 2025: € 66,467 ▼ 10% vs 2024 (€ 74,063) Favourable step	▼ 10%
Cash	€ 583 Cash 2022: € 583 First fiscal year in the series	€ 2,015 Cash 2023: € 2,015 ▲ 246% vs 2022 (€ 583) Favourable step	€ 2,902 Cash 2024: € 2,902 ▲ 44% vs 2023 (€ 2,015) Favourable step	€ 6,750 Cash 2025: € 6,750 ▲ 133% vs 2024 (€ 2,902) Favourable step	▲ 133%
Retained profit	€ 78,002 Retained profit 2022: € 78,002 First fiscal year in the series	€ 82,453 Retained profit 2023: € 82,453 ▲ 6% vs 2022 (€ 78,002) Favourable step	€ 32,000 Retained profit 2024: € 32,000 ▼ 61% vs 2023 (€ 82,453) Unfavourable step	€ 32,000 Retained profit 2025: € 32,000 Unchanged (€ 32,000) Unchanged
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 67,473 Dividend 2024: € 67,473 Unchanged (€ 0) Unchanged	€ 11,711 Dividend 2025: € 11,711 ▼ 83% vs 2024 (€ 67,473) Unchanged	▼ 83%
Bank debt	€ 82,426 Bank debt 2022: € 82,426 First fiscal year in the series	€ 74,249 Bank debt 2023: € 74,249 ▼ 10% vs 2022 (€ 82,426) Favourable step	€ 48,468 Bank debt 2024: € 48,468 ▼ 35% vs 2023 (€ 74,249) Favourable step	€ 22,136 Bank debt 2025: € 22,136 ▼ 54% vs 2024 (€ 48,468) Favourable step	▼ 54%
Balance sheet total	€ 186,336 Balance sheet total 2022: € 186,336 First fiscal year in the series	€ 172,037 Balance sheet total 2023: € 172,037 ▼ 8% vs 2022 (€ 186,336) Unchanged	€ 111,063 Balance sheet total 2024: € 111,063 ▼ 35% vs 2023 (€ 172,037) Unchanged	€ 103,467 Balance sheet total 2025: € 103,467 ▼ 7% vs 2024 (€ 111,063) Unchanged	▼ 7%

Key figures of INFILISA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to INFILISA?

What happened at INFILISA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 10, 2026 New annual accounts for financial year 2025: profit of € 11,711 (▼ 31% vs 2024). Source: NBB ↗
Jul 2, 2019 New establishment in Doische. KBO
Jul 2, 2019 Start of the company according to the CBE. KBO

In short

From € 1,341 profit in 2022 to € 11,711 profit in 2025.

Paid € 14,198 in corporate taxes since 2022.

Best year ever: 2024, with € 17,019 profit.

Paid out € 79,184 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Nicolas Vekeman

INFILISA

Behind INFILISA is Nicolas Vekeman.

Directors

According to the 2025 annual accounts

Nicolas Vekeman

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Route d'Agimont (VOD) 84 box A

5680 Doische

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0729.702.789

VAT number

BE 0729.702.789

Registered office

Route d'Agimont (VOD) 84 bus A, 5680 Doische

Names & denominations

INFILISA

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

2 July 2019

Peppol

Active · Active since 5 Nov 2025

Activities · NACE

Activiteiten van verpleegkundigen en verloskundigen

Verpleegkundige activiteiten

Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen

Detailhandel in medische en orthopedische artikelen in gespecialiseerde winkels

View on CBE Public ↗ Annual accounts (NBB) ↗

INFILISA

Warning lights

Financials

What happened to INFILISA?

Management

Directors

Establishments

Establishment units

Details

Frequently asked questions